GlassScriptPhysician profile
M Ihsan Kaadan
NPI 1285138594
$7,544.64
in general payments reported to CMS, 2019-2025
7 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $889 · 2023: $2,251 · 2024: $4,169 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,028 · Food and Beverage: $2,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,027.97 |
| Food and Beverage | $2,628.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,654.15 | 2022-2023 | Turbohawk |
| Boston Scientific Corporation | $2,227.61 | 2022-2024 | Ekosonic |
| Penumbra, INC. | $1,716.31 | 2024 | Indigo System |
| Edwards Lifesciences Corporation | $409.50 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bard Peripheral Vascular, INC. | $339.50 | 2022-2023 | |
| Atricure, INC. | $127.74 | 2024 | |
| Janssen Scientific Affairs, LLC | $69.83 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw M Ihsan Kaadan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.